Insulin and its Analogs – Options, Formulations, and Efficacy

The WHO has recently added long-acting insulin analogs and biosimilars to its new Essential Medicines List (EML). The recent addition of detemir, glargine, and degludec to WHO's EML is an important step towards health equity. The advances in long-acting and rapid-acting insulin analogs, combined with improved glucose monitoring tools, enable people with diabetes to meet their individual glycemic goals effectively. On the occasion of our 9 th anniversary, we bring you an exclusive DIWAS session on “Insulin and its Analogs – Options, Formulations, and Efficacy” by experts in diabetology.

Join us on 6 th October 2022, 6:00 PM IST onwards! Speaker : Dr. Lakshmi Hariharan Topic : Insulin - Options and Formulations ##Click here for session highlights## Types of insulin Physiology of insulin secretion Short-acting and long-acting analogs##   Speaker : Dr. J S Kumar Topic: Insulin Analogs:…